For students in the biomedical sciences, attending conferences is a chance to share ideas and research experiences with colleagues from across the country, while learning about educational and career opportunities and building identities as scientists. Outcomes from student conference attendance may also help us to learn how students build and maintain scientific identities. At conferences over the past two years, we have witnessed undergraduate trainees from the more recently-established Building Infrastructure Leading to Diversity (BUILD) program joining colleagues from long-running NIGMS-supported grants, like Research Initiative for Scientific Enhancement (RISE) and Maximizing Access to Research Careers (MARC).
Since BUILD is a fairly new program, it’s been great to see how quickly its trainees have embraced the opportunities conferences have to offer, from simply meeting other program trainees and sharing stories about their research to making valuable networking connections. BUILD, established in 2014, is a component of the Diversity Program Consortium (DPC), which also includes the National Research Mentoring Network (NRMN) and the Coordination and Evaluation Center (CEC). The DPC is part of a broad, trans-NIH strategy to address new ways to promote diversity in the biomedical research workforce.
In recent years, BUILD trainees have been in high attendance at the NIGMS-supported Society for Advancement of Chicanos/Hispanics and Native Americans in Science (SACNAS) conference and the Annual Biomedical Research Conference for Minority Students (ABRCMS) . These conferences focus on broadening participation in biomedical research and introduce students to groundbreaking scientists.
During the BUILD networking sessions at both meetings, we heard students’ stories about their research and programs. We also had the opportunity to witness an element of students developing scientific identities—trading business cards.
Many BUILD students also made presentations on their research at the 2016 SACNAS and ABRCMS meetings, and eight of them received awards for posters and oral presentations. These awards are based on a variety of criteria, including knowledge of a subject area as well as experimental design. Because the DPC’s BUILD programs introduce undergraduate students to research through hands-on lab experience, it’s great to see that students are sharing their research findings, taking part in poster sessions and being recognized for their efforts.
Students’ interactions during networking sessions and scientific presentations complement another DPC goal: providing role models and mentors to students from a wide variety of backgrounds. Because evaluating program outcomes is integral to the DPC, we are evaluating whether these kinds of interactions help students persist in science careers and develop identities as scientists. It is our hope that what we learn from DPC interventions—such as promoting conference attendance among students—can be scaled to fit a larger audience and benefit students in other training programs.
I recently sat down with NIGMS-funded early career scientist Namandjé Bumpus to talk about her research and career path. Questions came from undergraduates across the country, including Thorne Varier in the Building Infrastructure Leading to Diversity program at the University of Alaska, Fairbanks. I invite you to watch the archived videocast and share it with students and postdocs in your labs and departments.
The Q&A was part of the Second Annual Early Investigator Lecture for Undergraduate Students. We launched the lecture series last year to highlight the achievements of our early career grantees and encourage students to pursue biomedical research careers.
Namandjé, an associate professor in the department of medicine, division of clinical pharmacology at Johns Hopkins University School of Medicine, started with a scientific presentation that walked us through her research investigating the mechanisms involved in HIV drug activation and metabolism. She also described an exciting new project that involves genotyping people to identify genetic variations that may also influence these processes. Then, during our conversation, she talked about when she knew she wanted to be a scientist (a professional society played a major role), how mentors have supported her along the way, what she would have done differently and why basic research is so important for medical advances. Some other highlights from the lecture are on Twitter (#ecilecture).
Much of what Namandjé shared relates to scientists at any career stage. I hope you and your trainees find the lecture as inspiring as I did.During the 2017 NIGMS Director’s Early Career Investigator Lecture, Namandjé Bumpus discussed her research on drug metabolism (left), answered questions about her career path (middle) and met with undergraduate students (right).
One question that has been asked about the Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators is how awardees will be affected by the fact that they cannot have additional NIGMS research grants. In response to this question, we reviewed the research project grant (RPG) funding history of all 707 Principal Investigators (PIs) who received an NIGMS R01 as an Early Stage Investigator (ESI) between Fiscal Years 2009 and 2015. The PIs were grouped by Year of PI, which ranges from Year 1 to Year 5 (five years is the typical length of an ESI R01 award). Year 1 is the year in which the PI was awarded his or her initial R01, and Year 2-Year 5 represent the subsequent years. The awards and funding history of each PI were confined to Fiscal Years 2009-2015; thus, all PIs are included in the Year 1 group, while those who received their initial R01 in 2013, for example, would only appear in the Year 1-Year 3 groups.
The distribution of NIGMS awards (including subprojects) for these PIs is depicted below.
Adding up the percentages of PIs with two and three awards, Figure 1 shows that the percentage of PIs with more than one active NIGMS award ranges from 2.8% in Year 1 to 13.9% in Year 5.
The NIGMS funding distribution of these PIs is depicted below; it includes administrative supplements. Figure 2 also shows the 2016 ESI MIRA funding distribution for comparison.
Figure 2 shows that the percentage of PIs with more than $250,000 in NIGMS funding ranges from 8.9% in Year 1 to 18.2% in Year 5. Figure 2 also shows that 2016 ESI MIRA recipients (who all received $250,000 or less in NIGMS funding) had a much higher probability of receiving between $200,000 and $250,000 in NIGMS funding than non-MIRA PIs who received $250,000 or less in NIGMS funding.
Combining the data used to generate the previous two figures reveals that the percentage of PIs with both one or fewer active NIGMS awards and $250,000 or less in NIGMS funding ranges from 91.1% in Year 1 to 81.9% in Year 5. The data also show that 77% of the PIs had one or fewer active NIGMS awards and $250,000 or less in NIGMS funding in all years.
Taken together, the above data imply that the majority of NIGMS ESI awardees will not be negatively affected by the ESI MIRA requirement of having only one NIGMS grant for a maximum of $250,000 in direct costs per year. Furthermore, a majority of ESIs may actually benefit from the high probability of receiving between $200,000 and $250,000 in NIGMS funding as an ESI MIRA recipient (in fact, 50% of 2016 ESI MIRA recipients received the maximum amount). We also hope that ESIs will benefit from the enhanced research flexibility of the MIRA program, as well as the planned increase in funding stability. We will continue to monitor the progress of the ESI MIRA program carefully to ensure that it is meeting the program’s objectives and enhancing the efficiency and effectiveness of the biomedical research enterprise.
Trying to navigate changes in NIH grant application policy can be a daunting task. Moreover, when these policy changes bypass the radar of applicants, the result can be an unwelcome outcome. This was the case most recently for many grant applicants who did not follow the new NIH policy limiting the types of appendix materials allowed for applications with due dates on or after January 25, 2017. This policy was first advertised last August to allow sufficient time for applicants to absorb the change. Unfortunately, many of the grant applications assigned to NIGMS came in for the January 25 receipt date with non-compliant appendix materials, resulting in their withdrawal by NIH. We at NIGMS are very aware of the pain and frustration felt by applicants and institutional authorized officials when applications are withdrawn. In the hope of minimizing the number of withdrawals due to non-compliant appendices for upcoming receipt dates, here are some important reminders:
One of the best resources to help you stay on top of new and upcoming changes is the Notices of NIH Policy Changes on the Office of Extramural Research website—please check this site frequently. And, as always, NIGMS program and review staff are available to answer any questions.
We’re hosting a webinar for potential applicants to the PRAT Program on Tuesday, March 28, from 12:00-1:30 p.m. EDT. PRAT is a three-year program providing outstanding laboratory research experiences in NIH’s Intramural Research Program (IRP), access to NIH’s extensive resources, mentorship, career development activities and networking. The program places special emphasis on training fellows in basic biomedical research areas including cell biology, biophysics, genetics, developmental biology, pharmacology, physiology, biological chemistry, computational biology, immunology, neuroscience, technology development and bioinformatics.
The next receipt date for applications is October 3, 2017. Applicants can be graduate students considering postdoctoral research opportunities or postdoctoral fellows with no more than two years of postdoctoral research experience by the time of appointment to the PRAT program (late summer 2018). All applications require connecting with an investigator in the NIH IRP in advance of writing the application.
To attend the webinar, join the Skype meeting shortly before 12:00 p.m. EDT and enter the conference ID 8368072. You can also attend by phone by calling 301-480-4255. Slides will be posted on the PRAT website following the event.
We look forward to talking with you about the PRAT Program.
NIH Staff Participating in March 28 Webinar
Jessica Faupel-Badger, Director, NIGMS PRAT Program
Kenneth Gibbs, Program Director, NIGMS
Erika Ginsburg, NCI Authorized Organization Representative/Signing Official
Last year, we launched the NIGMS Director’s Early Career Investigator Lecture series. Open to everyone in the scientific community, the lectures are directed at undergraduate students to introduce them to cutting-edge science while inspiring them to pursue biomedical research careers. The series also highlights the achievements of some of NIGMS’ early career grantees.
I’m excited to share that the 2017 lecture will be presented by Namandjé Bumpus, Ph.D., associate professor of medicine-division of clinical pharmacology at Johns Hopkins University School of Medicine. Namandjé is an NIGMS-funded recipient of the Presidential Early Career Award for Scientists and Engineers.
Her lecture, “Drug Metabolism, Pharmacogenetics and the Quest to Personalize HIV Treatment and Prevention,” will take place on the NIH campus on Wednesday, April 5, from 2:00-3:00 p.m. EDT. It will be videocast and archived on the NIH videocasting site.
Namandjé will describe her work examining the metabolism and distribution of antiretroviral drugs and their effects on cellular signaling pathways. She hopes that through a clearer understanding of these processes in cells and tissues, we can move toward predicting drug responses in a given person. After her talk, Namandjé will participate in a 30-minute question-and-answer session about her research and career path.
I hope you will encourage your students to watch the lecture and send in their questions for Namandjé. They can email them or tweet them using #ecilecture by March 29. They can also check out the inaugural lecture by Blake Wiedenheft, Ph.D., on “Bacteria, Their Viruses, and How They Taught Us to Perform Genome Surgery.”
I’m pleased to announce that NIGMS is the new home for the Science Education Partnership Awards (SEPA). These awards, which were transferred from NIH’s Division of Program Coordination, Planning, and Strategic Initiatives, support research and educational activities that complement other workforce diversity and training programs within NIH mission areas. The change will allow the SEPA program to be better integrated with other NIGMS capacity-building and research training programs and will increase opportunities for synergies between them.
The SEPA program promotes partnerships between biomedical and clinical researchers and pre-kindergarten to grade 12 teachers and schools, museums and science centers, and other educational organizations. In addition, the program provides students from underserved communities with opportunities to learn about research careers; supplies teachers with professional development in science content and teaching skills; and improves community health and science literacy through its science centers and museum exhibits.
SEPA will be housed in our Center for Research Capacity Building (CRCB), which supports research, research training, faculty development and research infrastructure improvements in states that historically have not received significant levels of research funding from NIH. It also supports faculty research development at institutions that have a historical mission focused on serving students from underrepresented groups.
We do not plan to alter the mission or goals of SEPA as a result of the transfer, and the program will continue to be administered by Tony Beck, who has served as its program director since 2001.
In addition to the currently active funding opportunity announcement (FOA) for national cryo-electron microscopy (cryo-EM) centers, NIH has issued an FOA for research education program grants for cryo-EM curriculum development. Both FOAs are part of a new NIH/Office of Strategic Coordination Common Fund program being led by NIGMS and the National Eye Institute (NEI).
The research education grants will support investigator-driven development and dissemination of online educational materials, such as video-based tutorials, novel self-paced learning approaches and computer-based educational tools, to instruct biomedical researchers in the application of cryo-EM techniques, theory and analysis. Techniques include cryo-EM single particle analysis and cryo-electron tomography. Applications are due by July 25, 2017, with optional letters of intent due one month earlier.
If you have questions about the research education grants announcement, please email NEI’s Houmam Araj or call him at 301-451-2020. Please also help us get the word out by letting your community know of this opportunity.
NIGMS is committed to ensuring that taxpayers get the best possible returns on their investments in fundamental biomedical research. As part of an NIH-wide commitment to enhancing stewardship, we regularly monitor trends in the Institute’s funding portfolio.
One of the most commonly cited metrics when discussing grants is success rate, calculated as the number of applications funded divided by the number of applications reviewed. As shown in Figure 1, the success rate for NIGMS research project grants (RPGs) was 29.6% in Fiscal Year (FY) 2016, the same as it was in FY 2015. Although we funded a record number of competing RPGs in FY 2016, we also received more applications than in FY 2015, leading to a level success rate. The first applications and grants for the Maximizing Investigators’ Research Award (MIRA) (R35) program are included in the FY 2016 RPG counts. The increase in RPG applications in FY 2016 has reversed the downward trend noted in last year’s analysis.
An alternative measure of the performance of our funding strategies and the health of our portfolio is the “cumulative investigator rate,” which indicates the proportion of investigators actively seeking funding who had at least one NIGMS grant in a given fiscal year. Figure 2 shows the number of investigators seeking NIGMS support increased by 40% between FY 2004-2014, but the number of NIGMS-funded principal investigators (PIs) remained relatively unchanged over that same period. As a result, the cumulative investigator rate steadily decreased. More recently, the cumulative investigator rate has increased slightly, as the number of applicants seeking support in FY 2013-2016 has stabilized and the number of PIs receiving support during this same period has grown by 10%.
As noted above, changes in the numbers of both competing applications and awards influence our success rate. The number of competing applications submitted is primarily driven by the research community, while the number of funded competing grants is affected by our funding policies, budget and existing commitments to active grants. As stated in our 2015 strategic plan, we have been making efforts to bolster support for investigator-initiated research through careful consideration of our portfolio and funding policies.
We’ve mentioned in previous funding trends posts that NIGMS does not use a strict percentile cutoff (“payline”) to make funding decisions. Instead, we take a variety of factors into account, including peer review scores, summary statements and reviews, the relevance of the research area to the Institute’s mission, overall portfolio diversity and an applicant’s other research support. The funding curves in Figure 3 show a significant number of applications each year are in the “fundable” range. In FY 2016, for example, NIGMS funded approximately 50% of applications that scored at the 24th percentile. This marks a drop from the 26th percentile in FY 2015, but it is higher than in any of the previous three years. Figure 4 displays the substantial percentile range of funded NIGMS competing R01s. It does not reflect data from the MIRA program, which is still in its early phases. NIGMS has been carefully monitoring the MIRA program and communicating its findings in separate Feedback Loop posts.
NIGMS is currently operating under a continuing resolution through April 28, meaning that the Institute’s budget is at a level similar to what it was in FY 2016. If the budget is flat for the remainder of FY 2017, we do not anticipate being able to maintain a success rate for RPGs as high as it has been over the past two years. However, as mentioned in last year’s funding trends post, NIGMS pursued a strategy in FY 2016 that included funding a balance of long-term and short-term awards. Because the funds from these short-term awards became available again this year, NIGMS should be able to support more competing grants in FY 2017 than would have been possible had we not implemented this funding strategy in FY 2016.
Moving forward, we will continue to use every available analytical tool to ensure that we maximize returns on the taxpayers’ investments by supporting a vibrant and diverse portfolio of outstanding fundamental biomedical research.
At the recent NIGMS Advisory Council meeting, the Division of Training, Workforce Development, and Diversity requested, and received, approval to write a new predoctoral T32 funding opportunity announcement (FOA), specifically tailored for predoctoral graduate programs in the basic sciences and designed to help catalyze the modernization of biomedical graduate education. The goal is to enable the community to develop and implement innovative approaches to education and mentoring that will more effectively and efficiently train future generations of outstanding biomedical researchers, and will allow graduate education to keep pace with the rapid evolution of the biomedical research enterprise. Taking into account the feedback we have received from various stakeholders over the past year, the new FOA will:
The intention is not to layer additional activities onto existing structures. Instead, this funding announcement is designed to allow for a creative reinvention of biomedical graduate education that preserves the best elements, while enhancing the focus on the development of research and professional skills by trainees.
We expect to issue the new T32 FOA this fall and to receive the first applications in May 2018. The new FOA will apply to all NIGMS predoctoral T32 training grants, except for the Medical Scientist Training Program (MSTP), which will remain on the parent T32 announcement for now. We plan in the future to develop a parallel FOA that is specific for the goals of the MSTP.
If you’re preparing an institutional RISE grant application, you might have questions about the funding opportunity announcement and data tables required for the upcoming May 25 receipt date. We’ll be available to discuss these topics during a webinar on Thursday, April 6, from 2:00-4:00 p.m. EDT. You may send questions before the webinar or post them in the chat box during the event.
To access the webinar, visit the WebEx Meeting page and enter meeting number 624 498 694 and the password “RISE2017.” If you are unable to attend online, you can join by phone by calling 1-877-668-4493 from anywhere in the United States or Canada and entering the meeting number above.
We look forward to talking to you about the RISE program.
NIGMS Staff Participating in April 6 Webinar
Division of Training, Workforce Development, and Diversity:
Anissa Brown, Program Director
Luis Cubano, Program Director
Shiva Singh, Undergraduate and Predoctoral Training Branch Chief
Office of Scientific Review:
Rebecca Johnson, Scientific Review Officer
Division of Extramural Activities:
Susan South, Grants Management Specialist
NIGMS has a longstanding interest in understanding the structure and dynamics of the biomedical research enterprise including its workforce and institutions. At the recent NIGMS Advisory Council meeting, we presented and received approval for a joint program between NIGMS and the National Science Foundation (NSF) on the Science of Science and Innovation Policy (SciSIP) . The goal of the program is to develop a portfolio of high quality research to provide scientific analysis of important aspects of the biomedical research landscape.
Among the areas of NIGMS’ interest is research that will:
The SciSIP program, which is managed by NSF’s Directorate for Social, Behavioral and Economic Sciences, is a leader in supporting research in this field. It funds research designed to advance the scientific basis of science and innovation policy, including developing models, analytical tools, data and metrics that can be applied in the science policy decision making process and concern the use and allocation of scarce scientific resources.
The two agencies have compatible and complementary programmatic goals, with NIGMS focusing on the biomedical research enterprise and NSF focusing on general science, technology, engineering and math. The coordinated management and funding of a joint research program in this field would have a positive, synergistic effect on the scope of research and can leverage the investments of both agencies.
We are modeling the program on our collaborations with NSF in other scientific fields that have similarly compatible goals between the two agencies. These include the joint programs for mathematical biology and the ecology and evolution of infectious diseases. As with those programs, NSF will issue a solicitation in the coming months that will be highlighted in the NIH Guide. Applications will be due in October 2017. Following a jointly-conducted peer review of these applications, meritorious proposals may be recommended for funding by either NSF or NIGMS.
If you’re preparing an institutional MARC U-STAR grant application, you might have questions about the funding opportunity announcement and data tables required for the upcoming May 25 receipt date. We’ll be available to discuss these topics during a webinar on Wednesday, March 22, from 2:00-3:30 p.m. EDT. You may send questions to me before the webinar or post them in the chat box during the event.
To access the webinar, visit the WebEx Meeting page and enter meeting number 624 460 843 and the password “NIGMS.” If you are unable to attend online, you can join by phone by calling 1-877-668-4493 from anywhere in the United States or Canada and entering the meeting number above.
We look forward to talking to you about the MARC U-STAR program.
NIGMS Staff Participating in March 22 Webinar
Division of Training, Workforce Development, and Diversity:
Sailaja Koduri, Program Director
Luis Cubano, Program Director
Shiva Singh, Undergraduate and Predoctoral Training Branch Chief
Office of Scientific Review:
Rebecca Johnson, Scientific Review Officer
Division of Extramural Activities:
Lori Burge, Grants Management Officer
As we’ve pointed out, it’s important to acknowledge your NIH funding in all your publications, including research articles, press releases and other documents about NIH-supported research. Your Notice of Award includes information about such acknowledgements (also see Requirements for Acknowledging NIH-Supported Research and Attribution of NIH/NIGMS Support).
If you have more than one NIGMS or NIH award, you should only cite the grant(s) that supported the research described in the publication. The specific aims should be the determining factor. This would apply even in cases where one of the authors on the article (e.g., a technician) works on multiple projects and is paid through multiple grants, or when equipment used in the reported work was purchased on a different grant.
Acknowledging multiple awards in a publication may be taken as an indicator of scientific overlap among the cited projects. This becomes important when your next application is being considered by reviewers, NIGMS Advisory Council members and NIGMS staff. For example, when considering support of research in well-funded laboratories, our Advisory Council expects the Institute to support projects only if they are highly promising and distinct from other funded work in the laboratory.
So, please take a moment to make sure that you are citing your grants accurately in your publications and avoid pitfalls when you send in your next application.
Catherine D. Lewis, director of the NIGMS Division of Cell Biology and Biophysics (CBB), retired in January after more than 30 years of service at the NIH. Throughout her career, Cathy was widely recognized for her scientific foresight and leadership, including the early recognition of important emerging research opportunities in molecular biology, biophysics and microscopy. Her tireless work behind the scenes ensured that these transformational new research approaches were seamlessly integrated into the NIH portfolio and able to grow rapidly.
Cathy earned an M.S. and Ph.D. in biochemistry from Princeton University and joined NIH in 1983 as a staff fellow at NIDDK in the lab of Gary Felsenfeld, where she studied chromatin structure and the regulation of beta-globin gene expression during development.
Her career at NIGMS started in 1989, when Cathy moved to the Institute as a program director in the Genetics Division—led at the time by Judith Greenberg. She managed grants on cell nuclear structure and function and was instrumental in the development of programs focused on epigenetic regulation. Eight years later, Cathy became CBB’s Biophysics Branch chief. In that role, she at one point managed nearly 400 grants, some of which led to breakthroughs such as the structure of the ribosome. She also initiated NIGMS programs focused on new single-molecule methods and nanotechnology. In 2006, Cathy took over as director of CBB. During this period, she oversaw changes in the direction of the NIGMS Protein Structure Initiative, promoted advances in high-resolution optical microscopy and cellular imaging, and led efforts to support atomic resolution cryo-electron microscopy, including a new Common Fund initiative.
During her tenure at NIH, Cathy received two NIH Director’s Awards, for her work on trans-NIH initiatives and her leadership on science education in elementary schools.
Cathy’s door was always open to all, and her advice was constantly sought by colleagues, not only in her own division, but widely across NIGMS and NIH.
Most importantly, Cathy maintained warm professional and personal relationships with those around her, while getting things done and influencing others. “Leading a division that worked well and where people respected each other and got along is something that I’m happy to have been involved in,” she says.
Working in the CBB division was fun, because she helped make it so. She will be missed.
At its January 2017 meeting, our Advisory Council endorsed a concept for a new program to support collaborative, team-based science. This initiative is the result of evaluations of our previous programs, recent research on the science of team science , and community input.
Many research questions in biomedical science can be pursued by single investigators and their close collaborators through single- or multi-principal investigator R01 grants. However, complex research questions may require the coordinated efforts of several research laboratories and closer collaborations among researchers with diverse areas of expertise. NIGMS recognizes the importance and benefits of supporting collaborative research teams when these are necessary to achieve important scientific breakthroughs or new understanding of phenomena.
NIGMS’ new Collaborative Program Grant is designed to support highly integrated, multidisciplinary research teams of three to six investigators who will address complex research questions, train and mentor new scientists, and impact scientific problems that would benefit from coordinated research support. The key application requirements are a single, integrated research program without subprojects and a multiple-principal investigator management plan. We expect to issue a funding opportunity announcement by the summer and, beginning in 2018, we will make four to six awards per year with annual direct costs ranging from $500,000 to $1.5 million. We plan to phase out our use of the P01 and most of our other center mechanisms. We will continue to support capacity building centers, such as those of the Institutional Development Award (IDeA) program, and to support the AIDS-Related Structural Biology program centers.